Search filters

List of works by Bernhard Englinger

Acquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expression

scientific article

Altered membrane rigidity via enhanced endogenous cholesterol synthesis drives cancer cell resistance to destruxins.

scientific article published on 22 May 2018

CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model

scientific article

Chronic arsenic trioxide exposure leads to enhanced aggressiveness via Met oncogene addiction in cancer cells

scientific article published on 28 March 2016

Design, synthesis, nuclear localization, and biological activity of a fluorescent duocarmycin analog, HxTfA.

scientific article published on 5 March 2018

Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer.

scientific article published on 7 September 2017

Lipid droplet-mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib

scientific article published on 16 February 2020

Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance

scientific article published on 17 January 2017

Lysosomal Sequestration Impairs the Activity of the Preclinical FGFR Inhibitor PD173074

Nanoformulations of anticancer FGFR inhibitors with improved therapeutic index

scientific article published on 16 August 2018

P01.02FIBROBLAST GROWTH FACTOR 4 CONTRIBUTES TO 3-DIMENSIONAL GROWTH OF HUMAN GLIOBLASTOMA.

scientific article published in September 2014

PCLN-06. NOVEL TUMOR-DERIVED MODELS OF CNS HGNET-BCOR PROVIDE INSIGHTS INTO UNDERLYING MOLECULAR MECHANISMS AND INNOVATIVE THERAPEUTIC OPTIONS

Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric Ependymoma

scientific article published on 01 July 2020

The Natural Fungal Metabolite Beauvericin Exerts Anticancer Activity In Vivo: A Pre-Clinical Pilot Study.

scientific article published on 24 August 2017

Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance.

scientific article

Paulina is supported by:

About Paulina

Help